The other doses of brexpiprazole tested in these studies did lead to a numerically greater reduction in PANSS score over placebo but did not reach statistical significance.
← all excerpts
New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics.
1
—
—